Comparative efficacy of lactic acid teat dip and TANUVAS teat protect on prevention of sub-clinical mastitis in dairy cows

Introduction Methodology

Twelve lactating dairy cows were selected from each dairy farm and a total number of 60 dairy cows from 5 dairy farms were selected for the trial. All the 60 dairy cows were screened for somatic cell counts in the milk using CMT kit and 60 dairy cows which are negative for subclinical mastitis were selected for the trial. In each dairy farm, for 6 lactating dairy cows, lactic acid were used as a teat dip post-milking and for the other 6 dairy cows, TANUVAS Teat Protect were sprayed on the teats post-milking. Thus in the 5 dairy farms, a total number of 30 dairy cows were receive post-milking teat dipping with lactic acid and another 30 dairy cows received TANUVAS Teat Protect spray after milking for one month. All the 60 cows were screened for sub -clinical mastitis using CMT Kit at weekly intervals up to one month.

Results and Discussion

On Farm Test on 'Lactic Acid Teat Dip on Prevention of Sub-clinical Mastitis in Dairy Cows' using CMT kit

Bovine mastitis is an infectious disease of the mammary glands of dairy cattle, with high worldwide prevalence at both the cow and udder quarter levels. Mastitis alter milk quality, reduce milk yield, and increase treatment and care costs, resulting in great economic losses to the dairy industry (Rajala-Schultz et al 2007) [2] . Detection of mastitis is generally based on indicators of the inflammation, such as somatic cell count (SCC), inflammatory cytokine, enzyme activity (e.g., LDH or NAGase), and the electrical conductivity However, California Mastitis Test (CMT) is widely used for preliminary detection of bovine mastitis, which is a cost effective, rapid, user friendly method used to measure the SCC in milk samples (Viguier et al 2009) [3] . Five dairy farms belonging to the five progressive dairy farmers of Coimbatore district were selected for the conduct of OFT programme. Twelve lactating dairy cows were selected from each dairy farm and a total number of 60 dairy cows from 5 dairy farms were selected for the trial. All the 60 dairy cows were screened for somatic cell counts in the milk using CMT kit and 60 dairy cows which are negative for sub-clinical mastitis were selected for the trial. In each dairy farm, for 6 lactating dairy cows, lactic acid was used as a teat dip post-milking and for the other 6 dairy cows, TANUVAS Teat Protect was sprayed on the teats post-milking. Thus in the 5 dairy farms, a total number of 30 dairy cows received post-milking teat dipping with lactic acid and another 30 dairy cows received TANUVAS Teat Protect spray after milking for one month. All the 60 cows were screened for sub-clinical mastitis using CMT Kit at weekly intervals up to one month. The presence of subclinical mastitis in the dairy cows received post -milking teat dipping with lactic acid is in 18 dairy cows (60.00%). The presence of subclinical mastitis in the dairy cows received TANUVAS Teat Protect spray after milking is in 13 dairy cows (43.33%).

Use of TANUVAS teat protect spray prevented the entry of the microbes in to the teat canal and decreased the somatic cell counts and preventing sub-clinical mastitis. Compared to the Lactic acid Teat Dip, TANUVAS Teat Protect more effectively prevented the sub-clinical mastitis. It is correlated with the findings of Wan-Ting Yang et al (2019) [4] that A. dahurica and R. officinale have heat-clearing, detoxifying, anti-inflammatory, and antibacterial activities and help maintain the normal histopathology of the mammary gland in dairy animals. TANUVAS teat protect is advantageous over the conventional lactic acid teat dip in terms of application, cost and effectiveness in preventing sub-clinical mastitis.

Conclusion

Mastitis in dairy cows is the most economically important disease and contributes to substantial losses to the farmers due to reduced milk production and high treatment costs. Hence, the study was conducted to found out the comparative efficacy of Lactic acid Teat Dip and TANUVAS Teat protect in preventing sub-clinical mastitis. The presence of subclinical mastitis in the dairy cows received post -milking teat dipping with lactic acid is in 18 dairy cows (60.00%). The presence of subclinical mastitis in the dairy cows received TANUVAS Teat Protect spray after milking is in 13 dairy cows (43.33%). TANUVAS teat protect is advantageous over the conventional lactic acid teat dip in terms of application, cost and effectiveness in preventing sub-clinical mastitis. Awareness was created among the dairy farmers about TANUVAS Teat Protect and preventing the occurrence of mastitis. The farmers will screen for sub-clinical mastitis regularly and mastitis will be prevented in dairy cows.

References

1. Abrahmsén M, Persson MY, Kanyima BM, Båge R. Prevalence of subclinical mastitis in dairy farms in urban and peri-urban areas of Kampala, Uganda. Tropical Animal Health and Production. 2014;46(1):99-105.
2. Rajala-Schultz PJ, Grohn YT, McCulloch CE, Guard CL. Effects of clinical mastitis on milk yield in dairy cows. Journal of Dairy Science. 1999;82(6):1213-1220.
3. Viguier C, Arora S, Gilmartin N, Welbeck K, O'Kennedy R. Mastitis detection: current trends and future perspectives. Trends in Biotechnology. 2009;27(8):486493.